Inulin, an increasingly studied dietary fiber, alters intestinal microbiota. The aim of this study was to assess whether inulin decreases intestinal colonization by multidrug resistant E. coli and to investigate its potential mechanisms of action. Mice with amoxicillin-induced intestinal dysbiosis mice were inoculated with extended spectrum beta-lactamase producing E. coli (ESBL-E. coli). The combination of inulin and pantoprazole (IP) significantly reduced ESBL-E. coli fecal titers, whereas pantoprazole alone did not and inulin had a delayed and limited effect. Fecal microbiome was assessed using shotgun metagenomic sequencing and qPCR. The efficacy of IP was predicted by increased abundance of 74 taxa, including two species of Adlercreutzia. Preventive treatments with A. caecimuris or A. muris also reduced ESBL-E. coli fecal titers. Fecal microbiota of mice effectively treated by IP was enriched in genes involved in inulin catabolism, production of propionate and expression of beta-lactamases. They also had increased beta-lactamase activity and decreased amoxicillin concentration. These results suggest that IP act through production of propionate and degradation of amoxicillin by the microbiota. The combination of pantoprazole and inulin is a potential treatment of intestinal colonization by multidrug-resistant E. coli. The ability of prebiotics to promote propionate and/or beta-lactamase producing bacteria may be used as a screening tool to identify potential treatments of intestinal colonization by multidrug resistant Enterobacterales.

Center for Research in Transplantation and Translational Immunology Nantes Université Inserm CHU Nantes Nantes France

CHU Nantes Clinical Pharmacology Department Nantes France

College of Applied Sciences Palestine Polytechnic University Hebron Palestine

Emergency Department CHU Nantes Nantes France

Nantes Université CHU Nantes Cibles et médicaments des infections et du cancer IICiMed Nantes France

Nantes Université INRAE Nantes France

Veterinary Research Institute Brno Czech Republic

See more in PubMed

Campos-Madueno EI, Moradi M, Eddoubaji Y, Shahi F, Moradi S, Bernasconi OJ, Moser AI, Endimiani A.. Intestinal colonization with multidrug-resistant Enterobacterales: screening, epidemiology, clinical impact, and strategies to decolonize carriers. Eur J Clin Microbiol Infect Dis. 2023;42(3):229–16. doi:10.1007/s10096-023-04548-2. PubMed DOI PMC

Sorbara MT, Dubin K, Littmann ER, Moody TU, Fontana E, Seok R, Leiner IM, Taur Y, Peled JU, van den Brink MRM. et al. Inhibiting antibiotic-resistant enterobacteriaceae by microbiota-mediated intracellular acidification. J Exp Med. 2019;216(1):84–98. doi:10.1084/jem.20181639. PubMed DOI PMC

Oliveira RA, Ng KM, Correia MB, Cabral V, Shi H, Sonnenburg JL, Huang KC, Xavier KB. Klebsiella michiganensis transmission enhances resistance to enterobacteriaceae gut invasion by nutrition competition. Nat Microbiol. 2020;5(4):630–641. doi:10.1038/s41564-019-0658-4. PubMed DOI

Osbelt L, Wende M, Almási É, Derksen E, Muthukumarasamy U, Lesker TR, Galvez EJC, Pils MC, Schalk E, Chhatwal P. et al. Klebsiella oxytoca causes colonization resistance against multidrug-resistant K. pneumoniae in the gut via cooperative carbohydrate competition. Cell Host Microbe. 2021;29(11):1663–1679.e7. doi:10.1016/j.chom.2021.09.003. PubMed DOI

Kim H-R, Eom Y-B. Synergistic activity of Equol and meropenem against Carbapenem-Resistant Escherichia coli. Antibiotics (Basel). 2021;10(2):161. doi:10.3390/antibiotics10020161. PubMed DOI PMC

Gjonbalaj M, Keith JW, Do MH, Hohl TM, Pamer EG, Becattini S. Antibiotic degradation by commensal microbes shields pathogens. Infect Immun. 2020;88(4):e00012–20. doi:10.1128/IAI.00012-20. PubMed DOI PMC

Léonard F, Andremont A, Leclerq B, Labia R, Tancrède C. Use of -lactamase-producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization. J Infect Dis. 1989;160(2):274–280. doi:10.1093/infdis/160.2.274. PubMed DOI

Stiefel U, Nerandzic MM, Pultz MJ, Donskey CJ. Gastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and clostridium difficile in cephalosporin-treated mice. Antimicrob Agents Chemother. 2014;58(8):4535–4542. doi:10.1128/AAC.02782-14. PubMed DOI PMC

Cubillos-Ruiz A, Alcantar MA, Donghia NM, Cárdenas P, Avila-Pacheco J, Collins JJ. An engineered live biotherapeutic for the prevention of antibiotic-induced dysbiosis. Nat Biomed Eng. 2022;6(7):910–921. doi:10.1038/s41551-022-00871-9. PubMed DOI

Mensink MA, Frijlink HW, van der Voort Maarschalk K, Hinrichs WLJ. Inulin, a flexible oligosaccharide I: review of its physicochemical characteristics. Carbohydr Polym. 2015;130:405–419. doi:10.1016/j.carbpol.2015.05.026. PubMed DOI

Baxter NT, Schmidt AW, Venkataraman A, Kim KS, Waldron C, Schmidt TM. Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers. mBio. 2019;10(1):e02566–18. doi:10.1128/mBio.02566-18. PubMed DOI PMC

Chijiiwa R, Hosokawa M, Kogawa M, Nishikawa Y, Ide K, Sakanashi C, Takahashi K, Takeyama H. Single-cell genomics of uncultured bacteria reveals dietary fiber responders in the mouse gut microbiota. Microbiome. 2020;8(1). doi:10.1186/s40168-019-0779-2. PubMed DOI PMC

Le Bastard Q, Chapelet G, Javaudin F, Lepelletier D, Batard E, Montassier E. The effects of inulin on gut microbial composition: a systematic review of evidence from human studies. Eur J Clin Microbiol Infect Dis. 2020;39(3):403–413. doi:10.1007/s10096-019-03721-w. PubMed DOI

Gregoire M, Berteau F, Bellouard R, Lebastard Q, Aubert P, Gonzales J, Javaudin F, Bessard A, Bemer P, Batard É. et al. A murine model to study the gut bacteria parameters during complex antibiotics like cefotaxime and ceftriaxone treatment. Comput Struct Biotechnol J. 2021;19:1423–1430. doi:10.1016/j.csbj.2021.02.019. PubMed DOI PMC

Zhu L, Qin S, Zhai S, Gao Y, Li L. Inulin with different degrees of polymerization modulates composition of intestinal microbiota in mice. FEMS Microbiol Lett. 2017;364(10). doi:10.1093/femsle/fnx075. PubMed DOI

Rodriguez J, Hiel S, Neyrinck AM, Le Roy T, Pötgens SA, Leyrolle Q, Pachikian BD, Gianfrancesco MA, Cani PD, Paquot N. et al. Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients. Gut. 2020;69(11):1975–1987. doi:10.1136/gutjnl-2019-319726. PubMed DOI PMC

Caballero S, Kim S, Carter RA, Leiner IM, Sušac B, Miller L, Kim GJ, Ling L, Pamer EG. Cooperating commensals restore colonization resistance to vancomycin-resistant Enterococcus faecium. Cell Host Microbe. 2017;21(5):592–602.e4. doi:10.1016/j.chom.2017.04.002. PubMed DOI PMC

Juhász J, Ligeti B, Gajdács M, Makra N, Ostorházi E, Farkas FB, Stercz B, Tóth Á, Domokos J, Pongor S. et al. Colonization Dynamics of Multidrug-Resistant Klebsiella pneumoniae Are Dictated by Microbiota-Cluster Group Behavior over Individual Antibiotic Susceptibility: A Metataxonomic Analysis. Antibiotics (Basel). 2021;10(3):268. doi:10.3390/antibiotics10030268. PubMed DOI PMC

Wang L, Wang Z, Lan Y, Tuo Y, Ma S, Liu X. Inulin attenuates blood–brain barrier permeability and alleviates behavioral disorders by modulating the TLR4/MyD88/NF-κB pathway in mice with chronic stress. J Agric Food Chem. 2023;71(36):13325–13337. doi:10.1021/acs.jafc.3c03568. PubMed DOI

Hoving LR, Katiraei S, Pronk A, Heijink M, Vonk KKD, Amghar-el Bouazzaoui F, Vermeulen R, Drinkwaard L, Giera M, van Harmelen V. et al. The prebiotic inulin modulates gut microbiota but does not ameliorate atherosclerosis in hypercholesterolemic APOE*3-Leiden.CETP mice. Sci Rep. 2018;8(1):16515. doi:10.1038/s41598-018-34970-y. PubMed DOI PMC

Le Guern R, Grandjean T, Stabler S, Bauduin M, Gosset P, Kipnis É, Dessein R. Gut colonisation with multidrug-resistant Klebsiella pneumoniae worsens Pseudomonas aeruginosa lung infection. Nat Commun. 2023;14(1):78. doi:10.1038/s41467-022-35767-4. PubMed DOI PMC

Stiefel U, Rao A, Pultz MJ, Jump RLP, Aron DC, Donskey CJ. Suppression of gastric acid production by proton pump inhibitor treatment facilitates colonization of the large intestine by vancomycin-resistant Enterococcus spp. And Klebsiella pneumoniae in clindamycin-treated mice. Antimicrob Agents Chemother. 2006;50(11):3905–3907. doi:10.1128/AAC.00522-06. PubMed DOI PMC

Ishnaiwer M, Bezabih Y, Javaudin F, Sassi M, Bemer P, Batard E, Dion M. In vitro and in vivo activity of new strains of Bacillus subtilis against ESBL-producing Escherichia coli: an experimental study. J Appl Microbiol. 2022;132(3):2270–2279. doi:10.1111/jam.15329. PubMed DOI

Danylec N, Stoll DA, Göbl A, Huch M, Rasko D. Draft genome sequences of 13 isolates of adlercreutzia equolifaciens, Eggerthella lenta, and gordonibacter urolithinfaciens, isolated from human fecal samples in Karlsruhe, Germany. Microbiol Resour Announc. 2020;9(8):e00017–20. doi:10.1128/MRA.00017-20. PubMed DOI PMC

Fu L, Niu B, Zhu Z, Wu S, Li W. CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics. 2012;28(23):3150–3152. doi:10.1093/bioinformatics/bts565. PubMed DOI PMC

Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinf. 2012;13(1):134. doi:10.1186/1471-2105-13-134. PubMed DOI PMC

Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–2120. doi:10.1093/bioinformatics/btu170. PubMed DOI PMC

Lu J, Breitwieser FP, Thielen P, Salzberg SL. Bracken: estimating species abundance in metagenomics data. PeerJ Comput Sci. 2017;3:e104. doi:10.7717/peerj-cs.104. DOI

Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20(1):257. doi:10.1186/s13059-019-1891-0. PubMed DOI PMC

Beresford-Jones BS, Forster SC, Stares MD, Notley G, Viciani E, Browne HP, Boehmler DJ, Soderholm AT, Kumar N, Vervier K. et al. The mouse gastrointestinal bacteria catalogue enables translation between the mouse and human gut microbiotas via functional mapping. Cell Host Microbe. 2022;30(1):124–138.e8. doi:10.1016/j.chom.2021.12.003. PubMed DOI PMC

Yin X, Jiang X-T, Chai B, Li L, Yang Y, Cole JR, Tiedje JM, Zhang T. Args-OAP v2.0 with an expanded SARG database and hidden Markov models for enhancement characterization and quantification of antibiotic resistance genes in environmental metagenomes. Bioinformatics. 2018;34(13):2263–2270. doi:10.1093/bioinformatics/bty053. PubMed DOI

Beghini F, McIver LJ, Blanco-Míguez A, Dubois L, Asnicar F, Maharjan S, Mailyan A, Manghi P, Scholz M, Thomas AM. et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife. 2021;10:e65088. doi:10.7554/eLife.65088. PubMed DOI PMC

Caspi R, Billington R, Keseler IM, Kothari A, Krummenacker M, Midford PE, Ong WK, Paley S, Subhraveti P, Karp PD. et al. The MetaCyc database of metabolic pathways and enzymes - a 2019 update. Nucleic Acids Res. 2020;48(D1):D445–D453. doi:10.1093/nar/gkz862. PubMed DOI PMC

Drula E, Garron M-L, Dogan S, Lombard V, Henrissat B, Terrapon N. The carbohydrate-active enzyme database: functions and literature. Nucleic Acids Res. 2022;50(D1):D571–D577. doi:10.1093/nar/gkab1045. PubMed DOI PMC

Moaligou C, Dion M, Ishnaiwer M, Dailly É, Batard É, Javaudin F. Pantoprazole promotes sustained intestinal carriage of multidrug-resistant Escherichia coli in amoxicillin-treated mice. J Appl Microbiol lxad. 2023;223(10). doi:10.1093/jambio/lxad223. PubMed DOI

Ni W, Cai X, Liang B, Cai Y, Cui J, Wang R. Effect of proton pump inhibitors on in vitro activity of tigecycline against several common clinical pathogens. PLOS ONE. 2014;9(1):e86715. doi:10.1371/journal.pone.0086715. PubMed DOI PMC

van den Bunt G, van Pelt W, Hidalgo L, Scharringa J, de Greeff SC, Schürch AC, Mughini-Gras L, Bonten MJM, Fluit AC. Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016. Euro Surveill. 2019;24(41):1800594. doi:10.2807/1560-7917.ES.2019.24.41.1800594. PubMed DOI PMC

Willems RPJ, van Dijk K, Ket JCF, Vandenbroucke-Grauls CMJE. Evaluation of the association between gastric acid suppression and risk of intestinal colonization with multidrug-resistant microorganisms: a systematic review and meta-analysis. JAMA Internal Medicine. 2020;180(4):561–571. doi:10.1001/jamainternmed.2020.0009. PubMed DOI PMC

Raffelsberger N, Buczek DJ, Svendsen K, Småbrekke L, Pöntinen AK, Löhr IH, Andreassen LLE, Simonsen GS, Sundsfjord A, Gravningen K. et al. Community carriage of ESBL-producing Escherichia coli and Klebsiella pneumoniae: a cross-sectional study of risk factors and comparative genomics of carriage and clinical isolates. mSphere. 2023;8(4):e0002523. doi:10.1128/msphere.00025-23. PubMed DOI PMC

Le Bastard Q, Berthelot L, Soulillou J-P, Montassier E. Impact of non-antibiotic drugs on the human intestinal microbiome. Expert Rev Mol Diagn. 2021;21(9):911–924. doi:10.1080/14737159.2021.1952075. PubMed DOI

O’Donoghue C, Solomon K, Fenelon L, Fitzpatrick F, Kyne L. Effect of proton pump inhibitors and antibiotics on the gut microbiome of hospitalised older persons. J Infect. 2016;72(4):498–500. doi:10.1016/j.jinf.2016.01.015. PubMed DOI

Liu W, Li X, Zhao Z, Pi X, Meng Y, Fei D, Liu D, Wang X. Effect of chitooligosaccharides on human gut microbiota and antiglycation. Carbohyd Polym. 2020;242:116413. doi:10.1016/j.carbpol.2020.116413. PubMed DOI

Chung YW, Gwak H-J, Moon S, Rho M, Ryu J-H, Dong Q. Functional dynamics of bacterial species in the mouse gut microbiome revealed by metagenomic and metatranscriptomic analyses. PloS One. 2020;15(1):e0227886. doi:10.1371/journal.pone.0227886. PubMed DOI PMC

Smith BJ, Miller RA, Schmidt TM, Suen G. Muribaculaceae genomes assembled from metagenomes suggest genetic drivers of differential response to acarbose treatment in mice. mSphere. 2021;6(6):e0085121. doi:10.1128/msphere.00851-21. PubMed DOI PMC

Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M. The controversial role of human gut lachnospiraceae. Microorganisms. 2020;8(4):E573. doi:10.3390/microorganisms8040573. PubMed DOI PMC

Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. The genus alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front Immunol. 2020;11:906. doi:10.3389/fimmu.2020.00906. PubMed DOI PMC

Ormerod KL, Wood DLA, Lachner N, Gellatly SL, Daly JN, Parsons JD, Dal’molin CGO, Palfreyman RW, Nielsen LK, Cooper MA. et al. Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals. Microbiome. 2016;4(1). doi:10.1186/s40168-016-0181-2. PubMed DOI PMC

Wu G, Zhang C, Wang J, Zhang F, Wang R, Shen J, Wang L, Pang X, Zhang X, Zhao L. et al. Diminution of the gut resistome after a gut microbiota-targeted dietary intervention in obese children. Sci Rep. 2016;6(1):24030. doi:10.1038/srep24030. PubMed DOI PMC

Montassier E, Valdés-Mas R, Batard E, Zmora N, Dori-Bachash M, Suez J, Elinav E. Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner. Nat Microbiol. 2021;6(8):1043–1054. doi:10.1038/s41564-021-00920-0. PubMed DOI PMC

Mayo B, Vázquez L, Flórez AB. Equol: a bacterial metabolite from the Daidzein Isoflavone and its presumed beneficial health effects. Nutrients. 2019;11(9):E2231. doi:10.3390/nu11092231. PubMed DOI PMC

Yu Z-T, Yao W, Zhu W-Y. Isolation and identification of equol-producing bacterial strains from cultures of pig faeces. FEMS Microbiol Lett. 2008;282(1):73–80. doi:10.1111/j.1574-6968.2008.01108.x. PubMed DOI

Liang W, Zhao L, Zhang J, Fang X, Zhong Q, Liao Z, Wang J, Guo Y, Liang H, Wang L. et al. Colonization potential to reconstitute a microbe community in pseudo germ-free mice after fecal microbe transplant from equol Producer. Front Microbiol. 2020;11:1221. doi:10.3389/fmicb.2020.01221. PubMed DOI PMC